Update on Business Immunity to COVID-19 Lawsuits

by Shawn Meehan, Global Head of Legal Solutions at Guidepoint Several years ago, the Harvard Business Review set forth a three-pronged test for defining experts as capable of consistently performing superior to one’s peers, producing concrete results, and demonstrating outcomes…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Allison Vickers In cases of medical malpractice, patient harm results from an exercised substandard quality of care. In contrast, medical maloccurrence is defined as one or more adverse outcomes during a medical procedure that are unrelated to the quality…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Shawn Meehan, Global Head of Legal Solutions at Guidepoint How soon will artificial intelligence transform health care? The U.S. Food & Drug Administration (FDA) seeks to answer that question over the coming months. The implications for patients, doctors, medical…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Gary Chodes, Litigation Finance Industry Pioneer and founder of industry leaders Oasis, Courthouse Investments and Signal Funding We are now seeing substantial litigation financing activity involving brand name hedge funds players as well as publicly-traded closed-end funds and business…

Read More